High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation

Jenny N. Tran, Oliver P. Günther, Karen R. Sherwood, Franz Fenninger, Lenka L. Allan, James Lan, Ruth Sapir-Pichhadze, Rene Duquesnoy, Frans Claas, Steven G.E. Marsh, W. Robert McMaster, Paul A. Keown*, Stirling Bryan, Timothy Caulfield, Ioannis Ragoussis, Karim Oualkacha, Kathryn Tinckam, Robert Liwski, Patricia Campbell, Heloise CardinalSacha A. De Serres, Chee Loong Saw, Michael Mengel, Banu Sis, Eric Wagner, Noureddine Berka, Bruce McManus, Marie Josée Hebert, Leonard J. Foster, Fabio Rossi, Christoph H. Borchers, Ciriaco A. Piccirillo, Constantin Polychronakos, Raymond Ng, Anthony Jevnikar, Pieter Cullis, Guido Filler, Harvey Wong, Bethany Foster, John Gill, S. Joseph Kim, Lee Anne Tibbles, Atul Humar, Steven Shechter, Prosanto Chaudhury, Nicolas Fernandez, Elizabeth Fowler, Bryce Kiberd, Jagbir Gill, Marcel Tilanus, Canada Working Group, France Working Group, Genome Canada Transplant Consortium, Germany Working Group, Hungary Working Group, Netherlands Working Group, New Zealand Working Group, United Kingdom Working Group, United States Working Group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Compatibility for human leukocyte antigen (HLA) genes between transplant donors and recipients improves graft survival but prospective matching is rarely performed due to the vast heterogeneity of this gene complex. To reduce complexity, we have combined next-generation sequencing and in silico mapping to determine transplant population frequencies and matching probabilities of 150 antibody-binding eplets across all 11 classical HLA genes in 2000 ethnically heterogeneous renal patients and donors. We show that eplets are more common and uniformly distributed between donors and recipients than the respective HLA isoforms. Simulations of targeted eplet matching shows that a high degree of overall compatibility, and perfect identity at the clinically important HLA class II loci, can be obtained within a patient waiting list of approximately 250 subjects. Internal epitope-based allocation is thus feasible for most major renal transplant programs, while regional or national sharing may be required for other solid organs.
Original languageEnglish
Article number583
JournalCommunications Biology
Volume4
Issue number1
DOIs
Publication statusPublished - 1 Dec 2021

Cite this